GABELLI FUNDS LLC
Q3 2022 13F-HR/A Holdings
Net value change ($000)
-893,845
(-6.9%)
New positions
72
Sold out positions
99
Turnover %
7.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ALLEGHANY CORP /DE | 35,874 | 107.7% |
| AMT | 31,151 | 379.1% |
| EW | 29,728 | NEW |
| Global Blood Therapeutics, Inc. | 28,832 | 4703.4% |
| Zendesk, Inc. | 28,635 | 161.8% |
| ChemoCentryx, Inc. | 27,487 | NEW |
| TSLA | 26,981 | NEW |
| AVALARA, INC. | 23,745 | NEW |
| NEE | 23,445 | 10.9% |
| COST | 22,054 | 65.1% |
Top Reduces (Value $000, Stocks/ETFs)
| NEM | -40,854 | -28.2% |
| EW | -34,244 | -100.0% |
| MTOR | -33,347 | -100.0% |
| SONY | -30,836 | -23.8% |
| CDKGBX | -28,128 | -100.0% |
| COHERENT INC | -28,020 | -100.0% |
| Mandiant, Inc. | -27,528 | -100.0% |
| Welbilt, Inc. | -26,397 | -100.0% |
| GOOGL | -26,383 | -23.8% |
| TERMINIX GLOBAL HOLDINGS INC | -26,045 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|